SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

Bringing Part 53 across the finish line

April 4, 2024, 9:26AMNuclear News

The U.S. Nuclear Regulatory Commission’s Regulatory Information Conference—“the RIC” as it’s commonly known—is an annual rite of spring for many nuclear energy professionals. Each...

Remembering Clyde Jupiter

October 31, 1928–March 31, 2024

April 4, 2024, 7:00AMNuclear News

Clyde Peter Jupiter passed away peacefully March 31, 2024, at the age of 95. Born October 31, 1928, in New Orleans, La., Jupiter attended public and parochial schools in New Orleans,...